4//SEC Filing
GOODMAN JESSE 4
Accession 0000950170-25-093302
CIK 0001652130other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 5:50 PM ET
Size
6.0 KB
Accession
0000950170-25-093302
Insider Transaction Report
Form 4
GOODMAN JESSE
Director
Transactions
- Sale
Common Stock
2025-07-01$9.23/sh−1,547$14,279→ 24,359 total - Sale
Common Stock
2025-06-30$9.56/sh−1,547$14,789→ 25,906 total
Footnotes (1)
- [F1]The reported sale of 3,094 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on March 31, 2025.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001756929
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 5:50 PM ET
- Size
- 6.0 KB